13,910
Views
112
CrossRef citations to date
0
Altmetric
Review

Key factors influencing ADME properties of therapeutic proteins: A need for ADME characterization in drug discovery and development

, , , &
Pages 229-245 | Received 05 Aug 2015, Accepted 29 Oct 2015, Published online: 08 Feb 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Haisheng Peng, Jiahe Wang, Jiayu Chen, Yanbo Peng, Xiaoxian Wang, Ying Chen, David L. Kaplan & Qun Wang. (2023) Challenges and opportunities in delivering oral peptides and proteins. Expert Opinion on Drug Delivery 20:10, pages 1349-1369.
Read now
Simone Esposito, Laura Orsatti & Vincenzo Pucci. (2022) Subcutaneous catabolism of peptide therapeutics: bioanalytical approaches and ADME considerations. Xenobiotica 52:8, pages 828-839.
Read now
Hsueh-Yuan Chang, Shengjia Wu, Yingyi Li, Wanying Zhang, Matthew Burrell, Carl I. Webster & Dhaval K. Shah. (2021) Brain pharmacokinetics of anti-transferrin receptor antibody affinity variants in rats determined using microdialysis. mAbs 13:1.
Read now
Mengjing Zhao, Huijie Xing, Min Chen, Dong Dong & Baojian Wu. (2020) Circadian clock-controlled drug metabolism and transport. Xenobiotica 50:5, pages 495-505.
Read now
Jin Niu, Weirong Wang & Daniele Ouellet. Mechanism-based pharmacokinetic and pharmacodynamic modeling for bispecific antibodies: challenges and opportunities. Expert Review of Clinical Pharmacology 0:0, pages 1-14.
Read now

Articles from other publishers (107)

Mateus Alves Batista, Ana Carolina de Jesus Silva, Carlos Henrique Tomich de Paula da Silva, Carlton Anthony Taft & Lorane Izabel da Silva Hage-Melim. 2024. Trends and Innovations in Energetic Sources, Functional Compounds and Biotechnology. Trends and Innovations in Energetic Sources, Functional Compounds and Biotechnology 455 495 .
Devan Buchanan, Ashley M. Pham, Sandeep K. Singh & Siva S. Panda. (2023) Molecular Hybridization of Alkaloids Using 1,2,3-Triazole-Based Click Chemistry. Molecules 28:22, pages 7593.
Crossref
Dalbir SinghAmit AggarwalRajiv Patel, Anwesha DasSaurabh Sharma, Birasen Behera, Rajashree Panigrahy, Surjendu Maity, Amanda R. Kirane, Harsha Kharkwal, Murugesan Sankaranarayanan, Pankaj Wadhwa, Azmat Ali KhanJamilah M. AlshehriSubhash Chander. (2023) Design, Synthesis, Anticancer and Antimicrobial Studies of 2‐Phenylthiazolidin‐4‐one Glycinamide Conjugates. ChemistrySelect 8:42.
Crossref
Dalbir Singh, Rajiv Patel, Amit Aggarwal, Anwesha Das, Saurabh Sharma, Birasen Behera, Rajashree Panigrahy, Amanda R. Kirane, Harsha Kharkwal, Piyush Kumar, Naveen Prakash Bokolia, Murugesan Sankaranarayanan & Subhash Chander. (2023) Phenylthiazolidin-4-one Piperazine Conjugates: Design, Synthesis, Anticancer and Antimicrobial Studies. Results in Chemistry, pages 101237.
Crossref
Durgalakshmi Rajendran & Natarajan Chandrasekaran. (2023) Molecular Interaction of Functionalized Nanoplastics with Human Hemoglobin. Journal of Fluorescence 33:6, pages 2257-2272.
Crossref
Mustafa M. Kadhim, Iman K. Kadhim, Safa K. Hachim, Sallah Ahmed Abdullaha, Taleeb Zedan Taban & Ahmed Mahdi Rheima. (2023) Aluminum Carbide Sheet-Like Materials as Promising Drug Delivery Systems for Anticancer Drug. Journal of Cluster Science 34:6, pages 2881-2889.
Crossref
Yoshiya Tanaka, Masafumi Kawanishi, Megumi Nakanishi, Hironori Yamasaki & Tsutomu Takeuchi. (2023) Efficacy and safety of anti-TNF multivalent NANOBODY® compound ‘ozoralizumab’ without methotrexate co-administration in patients with active rheumatoid arthritis: A 52-week result of phase III, randomised, open-label trial (NATSUZORA trial). Modern Rheumatology 33:5, pages 875-882.
Crossref
Yoshiya Tanaka, Masafumi Kawanishi, Megumi Nakanishi, Hironori Yamasaki & Tsutomu Takeuchi. (2023) Efficacy and safety of the anti-TNF multivalent NANOBODY® compound ozoralizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: A 52-week result of a Phase II/III study (OHZORA trial). Modern Rheumatology 33:5, pages 883-890.
Crossref
Mohammad Habibur Rahman Molla, Amer H. Asseri & Md. Shafiqul Islam. (2023) Integrated structure model-based virtual screening approaches identified anti-cancer agents against prostate cancer by targeting MAOB protein. Egyptian Journal of Medical Human Genetics 24:1.
Crossref
Aman MouryaNavnit Prajapati. (2023) Precision Deuteration in Search of Anticancer Agents: Approaches to Cancer Drug Discovery. Cancer Biotherapy and Radiopharmaceuticals.
Crossref
Sharmila Velusamy, Syed Abuthakir Mohamed Husain, Saud Alarifi, Vijaya Anand Mariadoss Arokia & Jeyam Muthusamy. (2023) Screening potential inhibitor from actinomycetes for Dihydrofolate reductase of Staphylococcus aureus – In vitro and in silico studies. Journal of King Saud University - Science 35:6, pages 102762.
Crossref
Honglin Dai, Fuqiang Yu, Hao Wang, Lingling Chi, Chao Gao, Xiaojie Si, Yutong Zhang, Zhuo Qian, Peirong Zhao, Yingnan Zhu, Hongmin Liu & Qiurong Zhang. (2023) Design, synthesis and antitumor activity evaluation of 2,4,6-trisubstituted quinazoline derivatives containing piperidine moiety. Medicinal Chemistry Research.
Crossref
Shuang-Qing Zhang & Feng Chen. (2023) Factors Influencing ADME Properties Of Drugs: Advances and Applications (Part II). Current Drug Metabolism 24:7, pages 480-481.
Crossref
Iman Akbarzadeh, Niloufar Rezaei, Saina Bazzazan, Maryam Naderi Mezajin, Afsoun Mansouri, Hamideh Karbalaeiheidar, Shamim Ashkezari, Zahra Salehi Moghaddam, Zahra Asghari Lalami & Ebrahim Mostafavi. (2023) In silico and in vitro studies of GENT-EDTA encapsulated niosomes: A novel approach to enhance the antibacterial activity and biofilm inhibition in drug-resistant Klebsiella pneumoniae. Biomaterials Advances 149, pages 213384.
Crossref
Amita Datta-Mannan, Bruce A. Molitoris, Yiqing Feng, Michelle M. Martinez, Ruben M. Sandoval, Robin M. Brown, Daniel Merkel, Johnny E. Croy & Kenneth W. Dunn. (2023) Intravital Microscopy Reveals Unforeseen Biodistribution Within the Liver and Kidney Mechanistically Connected to the Clearance of a Bifunctional Antibody. Drug Metabolism and Disposition 51:3, pages 403-412.
Crossref
Danni Ramdhani, Nita Listiani, Maula Eka Sriyani, Eva Maria W, Hiroshi Watabe, Resmi Mustarichie, Sri Agung Fitri Kusuma & Regaputra S. Janitra. (2023) Estrogen receptor targeting with genistein radiolabeled Technetium-99m as radiotracer of breast cancer: Its optimization, characterization, and predicting stability constants by DFT calculation. Heliyon 9:2, pages e13169.
Crossref
Mazin H. Hakim, Brian H. Jun, Adib Ahmadzadegan, Paulina M. Babiak, Qinghua Xu, Kevin P. Buno, Julie C. Liu, Arezoo M. Ardekani, Pavlos P. Vlachos & Luis Solorio. (2023) Investigation of macromolecular transport through tunable collagen hyaluronic acid matrices. Colloids and Surfaces B: Biointerfaces 222, pages 113123.
Crossref
Swati Mittal, Sujata Sawarkar, Gaurav Doshi, Prachi Pimple, Jenny Shah & Turabali Bana. 2023. Industrial Application of Functional Foods, Ingredients and Nutraceuticals. Industrial Application of Functional Foods, Ingredients and Nutraceuticals 725 783 .
Mohammad Yasir, Alok Shiomurti Tripathi, Prashant Shukla & Rahul Kumar Maurya. 2023. Protein-based Therapeutics. Protein-based Therapeutics 251 273 .
Pallavi Shah & Basant. 2023. Protein-based Therapeutics. Protein-based Therapeutics 163 198 .
Raffah Khamis Mahal, Salam Mohammrd Naser, Munthir Abdulwahid Abdulhussain, Ali Taha, Safa K. Hachim, Sallal A.H. Abdullaha, Mustafa M. Kadhim, Ahmed Mahdi Rheima & Taleeb Zedan Taban. (2022) First-principles studies on two-dimensional aluminum carbide as potential nanocarriers for drug delivery systems. Inorganic Chemistry Communications 145, pages 110010.
Crossref
Tsutomu Takeuchi, Masafumi Kawanishi, Megumi Nakanishi, Hironori Yamasaki & Yoshiya Tanaka. (2022) Phase II/III Results of a Trial of Anti–Tumor Necrosis Factor Multivalent NANOBODY Compound Ozoralizumab in Patients With Rheumatoid Arthritis. Arthritis & Rheumatology 74:11, pages 1776-1785.
Crossref
Shohei Oyama, Kosuke Ebina, Yuki Etani, Makoto Hirao, Masanao Kyuuma, Yasuyuki Fujii, Katsuya Iwata, Bunichiro Ogawa, Tomoya Hasegawa, Sasagu Kawano, Yutaka Nakanishi, Seiji Okada & Ken Nakata. (2022) A novel anti-TNF-α drug ozoralizumab rapidly distributes to inflamed joint tissues in a mouse model of collagen induced arthritis. Scientific Reports 12:1.
Crossref
Sunday N. Okafor, Pavimol Angsantikul & Hashim Ahmed. (2022) Discovery of Novel HIV Protease Inhibitors Using Modern Computational Techniques. International Journal of Molecular Sciences 23:20, pages 12149.
Crossref
Anik Banik, Sheikh Rashel Ahmed, Emran Hossain Sajib, Anamika Deb, Shiuly Sinha & Kazi Faizul Azim. (2021) Identification of potential inhibitory analogs of metastasis tumor antigens (MTAs) using bioactive compounds: revealing therapeutic option to prevent malignancy. Molecular Diversity 26:5, pages 2473-2502.
Crossref
Ana Figueiras, Cátia Domingues, Ivana Jarak, Ana Isabel Santos, Ana Parra, Alberto Pais, Carmen Alvarez-Lorenzo, Angel Concheiro, Alexander Kabanov, Horacio Cabral & Francisco Veiga. (2022) New Advances in Biomedical Application of Polymeric Micelles. Pharmaceutics 14:8, pages 1700.
Crossref
Wenying Jian, Cong Wei & and Jinping Gan. 2022. Bioanalytical Aspects in Biological Therapeutics. Bioanalytical Aspects in Biological Therapeutics 277 307 .
Kathryn Ball, Gerard Bruin, Enrique Escandón, Christoph Funk, Joao N.S. Pereira, Tong-Yuan Yang & Hongbin Yu. (2022) Characterizing the Pharmacokinetics and Biodistribution of Therapeutic Proteins: An Industry White Paper. Drug Metabolism and Disposition 50:6, pages 858-866.
Crossref
Markus Walles, Michael Berna, Wenying Jian, Simon Hauri, Shawna Hengel, Lloyd King, John C. Tran, Cong Wei, Keyang Xu & Xiaochun Zhu. (2022) A Cross Company Perspective on the Assessment of Therapeutic Protein Biotransformation. Drug Metabolism and Disposition 50:6, pages 846-857.
Crossref
Jayaprakasam Bolleddula, Kevin Brady, Gerard Bruin, Anthony Lee, Jennifer A. Martin, Markus Walles, Keyang Xu, Tong-Yuan Yang, Xiaochun Zhu & Hongbin Yu. (2022) Absorption, Distribution, Metabolism, and Excretion of Therapeutic Proteins: Current Industry Practices and Future Perspectives. Drug Metabolism and Disposition 50:6, pages 837-845.
Crossref
Faiza Fayyaz, Muhammad Yar, Adnan Gulzar & Khurshid Ayub. (2022) First principles calculations of the adsorption of fluorouracil and nitrosourea on CTF-0; organic frameworks as drug delivery systems for cancer treatment. Journal of Molecular Liquids 356, pages 118941.
Crossref
Yurong Lai, Xiaoyan Chu, Li Di, Wei Gao, Yingying Guo, Xingrong Liu, Chuang Lu, Jialin Mao, Hong Shen, Huaping Tang, Cindy Q. Xia, Lei Zhang & Xinxin Ding. (2022) Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development. Acta Pharmaceutica Sinica B 12:6, pages 2751-2777.
Crossref
Kris Dammen-Brower, Paige Epler, Stanley Zhu, Zachary J. Bernstein, Paul R. Stabach, Demetrios T. Braddock, Jamie B. Spangler & Kevin J. Yarema. (2022) Strategies for Glycoengineering Therapeutic Proteins. Frontiers in Chemistry 10.
Crossref
Marco Cavaco, Miguel A. R. B. Castanho & Vera Neves. (2022) The Use of Antibody-Antibiotic Conjugates to Fight Bacterial Infections. Frontiers in Microbiology 13.
Crossref
Katarzyna Masłowska, Ewa Witkowska, Dagmara Tymecka, Paweł Krzysztof Halik, Aleksandra Misicka & Ewa Gniazdowska. (2022) Synthesis, Physicochemical and Biological Study of Gallium-68- and Lutetium-177-Labeled VEGF-A165/NRP-1 Complex Inhibitors Based on Peptide A7R and Branched Peptidomimetic. Pharmaceutics 14:1, pages 100.
Crossref
Anik Banik, Sheikh Rashel Ahmed, Hlamrasong Marma, Shiuly Sinha, Md. Mostafigur Rahman Khan & Kawsar Miah. (2022) Targeting mucormycosis polyprotein (RVT_1 region) through antifungal phytochemicals: An in-silico perspective. Informatics in Medicine Unlocked 29, pages 100851.
Crossref
Kelly Covert, Hongmei Niu & Sanjeev Bhardwaj. 2022. An Introduction to Bioanalysis of Biopharmaceuticals. An Introduction to Bioanalysis of Biopharmaceuticals 75 102 .
Sanjeev Bhardwaj, Inderpal Singh & Matthew Halquist. 2022. An Introduction to Bioanalysis of Biopharmaceuticals. An Introduction to Bioanalysis of Biopharmaceuticals 1 17 .
Mahmud Hasan & Robert E. StratfordJr.Jr.. 2022. The ADME Encyclopedia. The ADME Encyclopedia 164 178 .
Robert E. StratfordJr.Jr.. 2022. The ADME Encyclopedia. The ADME Encyclopedia 199 210 .
Robert E. Stratford,. 2022. The ADME Encyclopedia. The ADME Encyclopedia 300 308 .
Mei Han, Richard Smith & Dan A. Rock. 2022. Capillary Electrophoresis-Mass Spectrometry. Capillary Electrophoresis-Mass Spectrometry 15 47 .
Ernesto M. Martell, Melaine González-Garcia, Ludger Ständker & Anselmo J. Otero-González. (2021) Host defense peptides as immunomodulators: The other side of the coin. Peptides 146, pages 170644.
Crossref
Nurdjannah Jane Niode, Aryani Adji, Jimmy Rimbing, Max Tulung, Mohammed Alorabi, Ahmed M. El-Shehawi, Rinaldi Idroes, Ismail Celik, Fatimawali, Ahmad Akroman Adam, Kuldeep Dhama, Gomaa Mostafa-Hedeab, Amany Abdel-Rahman Mohamed, Trina Ekawati Tallei & Talha Bin Emran. (2021) In Silico and In Vitro Evaluation of the Antimicrobial Potential of Bacillus cereus Isolated from Apis dorsata Gut against Neisseria gonorrhoeae. Antibiotics 10:11, pages 1401.
Crossref
Andrew T. Lucas, Amber Moody, Allison N. Schorzman & William C. Zamboni. (2021) Importance and Considerations of Antibody Engineering in Antibody-Drug Conjugates Development from a Clinical Pharmacologist’s Perspective. Antibodies 10:3, pages 30.
Crossref
Cassie M. Bryan, Gabriel J. RocklinMatthew J. Bick, Alex FordSonia Majri-Morrison, Ashley V. KrollChad J. Miller, Lauren Carter, Inna GoreshnikAlex KangFrank DiMaio, Kristin V. TarbellDavid Baker. (2021) Computational design of a synthetic PD-1 agonist. Proceedings of the National Academy of Sciences 118:29.
Crossref
Kiara Fairman, Miao Li, Baitang Ning & Annie Lumen. (2021) Physiologically based pharmacokinetic (PBPK) modeling of RNAi therapeutics: Opportunities and challenges. Biochemical Pharmacology 189, pages 114468.
Crossref
Aida Kouhi, Vyshnavi Pachipulusu, Talya Kapenstein, Peisheng Hu, Alan L. Epstein & Leslie A. Khawli. (2021) Brain Disposition of Antibody-Based Therapeutics: Dogma, Approaches and Perspectives. International Journal of Molecular Sciences 22:12, pages 6442.
Crossref
Jennifer M. Nguyen, Xiaoxiao Liu, Maureen DeLoffi, Amarande Murisier, Szabolcs Fekete, Davy Guillarme & Matthew A. Lauber. (2021) Aptamer-based immunoaffinity LC-MS using an ultra-short column for rapid attomole level quantitation of intact mAbs. Journal of Chromatography B 1173, pages 122694.
Crossref
Péter Judák, Simone Esposito, Gilles Coppieters, Peter Van Eenoo & Koen Deventer. (2021) Doping control analysis of small peptides: A decade of progress. Journal of Chromatography B 1173, pages 122551.
Crossref
Mei Han, Yunan Wang, Kevin Cook, Noor Bala, Marcus Soto, Dan A. Rock, Josh T. Pearson & Brooke M. Rock. (2021) Universal Automated Immunoaffinity Purification-CE−MS Platform for Accelerating Next Generation Biologic Design. Analytical Chemistry 93:13, pages 5562-5569.
Crossref
Sunil Kumar Dubey, Shraddha Parab, Neha Dabholkar, Mukta Agrawal, Gautam Singhvi, Amit Alexander, Ranjeet Ajit Bapat & Prashant Kesharwani. (2021) Oral peptide delivery: challenges and the way ahead. Drug Discovery Today 26:4, pages 931-950.
Crossref
Yu Tang & Yanguang Cao. (2021) Modeling Pharmacokinetics and Pharmacodynamics of Therapeutic Antibodies: Progress, Challenges, and Future Directions. Pharmaceutics 13:3, pages 422.
Crossref
Mark A. Bryniarski, Bei Zhao, Lee D. Chaves, Jakob Hauge Mikkelsen, Benjamin M. Yee, Rabi Yacoub, Shichen Shen, Mette Madsen & Marilyn E. Morris. (2021) Immunoglobulin G Is a Novel Substrate for the Endocytic Protein Megalin. The AAPS Journal 23:2.
Crossref
Hobart Rogers, Oluseyi Adeniyi, Anuradha Ramamoorthy, Samantha Bailey & Michael Pacanowski. (2021) Clinical Pharmacology Studies Supporting Oligonucleotide Therapy Development: An Assessment of Therapies Approved and in Development Between 2012 and 2018. Clinical and Translational Science 14:2, pages 468-475.
Crossref
Trevor S. Anderson, Amanda L. Wooster, Ninh M. La-Beck, Dipongkor Saha & Devin B. Lowe. (2020) Antibody-drug conjugates: an evolving approach for melanoma treatment. Melanoma Research 31:1, pages 1-17.
Crossref
Hsuan-Ping Chang, Se Jin Kim & Dhaval K. Shah. (2021) Whole-Body Pharmacokinetics of Antibody in Mice Determined using Enzyme-Linked Immunosorbent Assay and Derivation of Tissue Interstitial Concentrations. Journal of Pharmaceutical Sciences 110:1, pages 446-457.
Crossref
Sohaib Mahri, Aurélie Rondon, Tobias Wilms, Cynthia Bosquillon & Rita Vanbever. (2021) Biodistribution and elimination pathways of PEGylated recombinant human deoxyribonuclease I after pulmonary delivery in mice. Journal of Controlled Release 329, pages 1054-1065.
Crossref
Brian Geist, Songmao Zheng & Yan Xu. 2021. Remington. Remington 437 462 .
Mahmud Hasan & Robert E. StratfordJrJr. 2021. The ADME Encyclopedia. The ADME Encyclopedia 1 15 .
Robert E. Stratford. 2021. The ADME Encyclopedia. The ADME Encyclopedia 1 12 .
Robert E. Stratford,. 2021. The ADME Encyclopedia. The ADME Encyclopedia 1 10 .
David W. Meyer, Fu Li & Robert P. Lyon. 2021. Quantitative Analysis of Cellular Drug Transport, Disposition, and Delivery. Quantitative Analysis of Cellular Drug Transport, Disposition, and Delivery 357 382 .
Bo An, Ming Zhang, Jie Pu, Yang Qu, Shichen Shen, Shaolian Zhou, Luca Ferrari, Faye Vazvaei & Jun Qu. (2020) Toward Accurate and Robust Liquid Chromatography–Mass Spectrometry-Based Quantification of Antibody Biotherapeutics in Tissues. Analytical Chemistry 92:22, pages 15152-15161.
Crossref
Nguyen Hoang AnhJung Eun MinSun Jo KimNguyen Phuoc Long. (2020) Biotherapeutic Products, Cellular Factories, and Multiomics Integration in Metabolic Engineering. OMICS: A Journal of Integrative Biology 24:11, pages 621-633.
Crossref
Nkiruka Ibeanu, Raphael Egbu, Lesley Onyekuru, Hoda Javaheri, Peng Tee Khaw, Gareth R. Williams, Steve Brocchini & Sahar Awwad. (2020) Injectables and Depots to Prolong Drug Action of Proteins and Peptides. Pharmaceutics 12:10, pages 999.
Crossref
Shihao Hu & David Z. D’Argenio. (2020) Predicting monoclonal antibody pharmacokinetics following subcutaneous administration via whole-body physiologically-based modeling. Journal of Pharmacokinetics and Pharmacodynamics 47:5, pages 385-409.
Crossref
Zi-ying Chen, Dan-feng Xie, Zhi-yuan Liu, Yong-qi Zhong, Jing-yan Zeng, Zheng Chen & Xin-lin Chen. (2020) Identification of the significant pathways of Banxia Houpu decoction in the treatment of depression based on network pharmacology. PLOS ONE 15:9, pages e0239843.
Crossref
Wilson Z. Shou. (2020) Current status and future directions of high-throughput ADME screening in drug discovery. Journal of Pharmaceutical Analysis 10:3, pages 201-208.
Crossref
Jessica K. Simmons, Patrick J. Burke, Julia H. Cochran, Paul G Pittman & Robert P. Lyon. (2020) Reducing the antigen-independent toxicity of antibody-drug conjugates by minimizing their non-specific clearance through PEGylation. Toxicology and Applied Pharmacology 392, pages 114932.
Crossref
Arne Krüger, Vinicius Gonçalves Maltarollo, Carsten Wrenger & Thales Kronenberger. 2020. Drug Discovery and Development - New Advances. Drug Discovery and Development - New Advances.
David W Meyer, Lauren B Bou, Sara Shum, Mechthild Jonas, Martha E Anderson, Joe Z Hamilton, Joshua H Hunter, Serena W Wo, Abbie O Wong, Nicole M Okeley & Robert P Lyon. (2020) An in Vitro Assay Using Cultured Kupffer Cells Can Predict the Impact of Drug Conjugation on in Vivo Antibody Pharmacokinetics. Molecular Pharmaceutics 17:3, pages 802-809.
Crossref
Hiroshi Sugimoto, Susan Chen & Mark G. Qian. (2020) Pharmacokinetic Characterization and Tissue Distribution of Fusion Protein Therapeutics by Orthogonal Bioanalytical Assays and Minimal PBPK Modeling. Molecules 25:3, pages 535.
Crossref
Ninad Varkhede, Rupesh Bommana, Christian Schöneich & M. Laird Forrest. (2020) Proteolysis and Oxidation of Therapeutic Proteins After Intradermal or Subcutaneous Administration. Journal of Pharmaceutical Sciences 109:1, pages 191-205.
Crossref
Hannah M. Johnston, Kristof Pota, Madalyn M. Barnett, Olivia Kinsinger, Paige Braden, Timothy M. Schwartz, Emily Hoffer, Nishanth Sadagopan, Nam Nguyen, Yu Yu, Paulina Gonzalez, Gyula Tircsó, Hongli Wu, Giridhar Akkaraju, Michael J. Chumley & Kayla N. Green. (2019) Enhancement of the Antioxidant Activity and Neurotherapeutic Features through Pyridol Addition to Tetraazamacrocyclic Molecules. Inorganic Chemistry 58:24, pages 16771-16784.
Crossref
Alex Eli Pottash, Christopher Kuffner, Madeleine Noonan-Shueh & Steven M. Jay. (2019) Protein-based vehicles for biomimetic RNAi delivery. Journal of Biological Engineering 13:1.
Crossref
Marie Viala & Diego Tosi. (2020) Déterminer la dose à injecter lors des premières études cliniques menées avec un anticorps monoclonal. médecine/sciences 35:12, pages 1121-1129.
Crossref
Susan R. Crowell, Kathryn Wang, Amin Famili, Whitney Shatz, Kelly M. Loyet, Vincent Chang, Yanqiu Liu, Saileta Prabhu, Amrita V. Kamath & Robert F. Kelley. (2019) Influence of Charge, Hydrophobicity, and Size on Vitreous Pharmacokinetics of Large Molecules. Translational Vision Science & Technology 8:6, pages 1.
Crossref
Brooke M. Rock & Robert S. Foti. (2019) Pharmacokinetic and Drug Metabolism Properties of Novel Therapeutic Modalities. Drug Metabolism and Disposition 47:10, pages 1097-1099.
Crossref
A. R. Satvik Iyengar, Shreya Gupta, Snehal Jawalekar & Abhay H. Pande. (2019) Protein Chimerization: A New Frontier for Engineering Protein Therapeutics with Improved Pharmacokinetics. Journal of Pharmacology and Experimental Therapeutics 370:3, pages 703-714.
Crossref
Kayla N. Green, Kristof Pota, Gyula Tircsó, Réka Anna Gogolák, Olivia Kinsinger, Collin Davda, Kimberly Blain, Samantha M. Brewer, Paulina Gonzalez, Hannah M. Johnston & Giridhar Akkaraju. (2019) Dialing in on pharmacological features for a therapeutic antioxidant small molecule. Dalton Transactions 48:33, pages 12430-12439.
Crossref
Andrew T. Lucas, Ryan Robinson, Allison N. Schorzman, Joseph A. Piscitelli, Juan F. Razo & William C. Zamboni. (2019) Pharmacologic Considerations in the Disposition of Antibodies and Antibody-Drug Conjugates in Preclinical Models and in Patients. Antibodies 8:1, pages 3.
Crossref
Christopher Schultz. (2018) Targeting the extracellular matrix for delivery of bioactive molecules to sites of arthritis. British Journal of Pharmacology 176:1, pages 26-37.
Crossref
Rajiv Bajracharya, Jae Geun Song, Seung Yun Back & Hyo-Kyung Han. (2019) Recent Advancements in Non-Invasive Formulations for Protein Drug Delivery. Computational and Structural Biotechnology Journal 17, pages 1290-1308.
Crossref
Xing Jing, Yan Hou, William Hallett, Chandrahas G. Sahajwalla & Ping Ji. 2019. Therapeutic Enzymes: Function and Clinical Implications. Therapeutic Enzymes: Function and Clinical Implications 115 129 .
Dennis R. Goulet, Michael J. Watson, Susan H. Tam, Adam Zwolak, Mark L. Chiu, William M. Atkins & Abhinav Nath. (2018) Toward a Combinatorial Approach for the Prediction of IgG Half-Life and Clearance. Drug Metabolism and Disposition 46:12, pages 1900-1907.
Crossref
Si Mou, Yue Huang & Anton Rosenbaum. (2018) ADME Considerations and Bioanalytical Strategies for Pharmacokinetic Assessments of Antibody-Drug Conjugates. Antibodies 7:4, pages 41.
Crossref
Chuan Shi, Shalom Goldberg, Tricia Lin, Vadim Dudkin, Wayne Widdison, Luke Harris, Sharon Wilhelm, Yazen Jmeian, Darryl Davis, Karyn O'Neil, Naidong Weng & Wenying Jian. (2018) Bioanalytical workflow for novel scaffold protein–drug conjugates: quantitation of total Centyrin protein, conjugated Centyrin and free payload for Centyrin–drug conjugate in plasma and tissue samples using liquid chromatography–tandem mass spectrometry. Bioanalysis 10:20, pages 1651-1665.
Crossref
Margarida Viola, Joana Sequeira, Raquel Seiça, Francisco Veiga, João Serra, Ana C. Santos & António J. Ribeiro. (2018) Subcutaneous delivery of monoclonal antibodies: How do we get there?. Journal of Controlled Release 286, pages 301-314.
Crossref
Weirong Wang, Jocelyn Leu, Rebecca Watson, Zhenhua Xu & Honghui Zhou. (2018) Investigation of the Mechanism of Therapeutic Protein-Drug Interaction Between Methotrexate and Golimumab, an Anti-TNFα Monoclonal Antibody. The AAPS Journal 20:3.
Crossref
Michael R. Turner & Sathy V. Balu-Iyer. (2018) Challenges and Opportunities for the Subcutaneous Delivery of Therapeutic Proteins. Journal of Pharmaceutical Sciences 107:5, pages 1247-1260.
Crossref
Katarzyna Sidoryk, Piotr Cmoch, Marta Świtalska, Bartosz Trzaskowski, Joanna Wietrzyk & Marcin Cybulski. (2018) Efficient glycosylation of natural Danshensu and its enantiomer by sugar and 2-deoxy sugar donors. Carbohydrate Research 460, pages 19-28.
Crossref
P.O. Venkataramana Reddy, M. Hridhay, Kumar Nikhil, Shahid Khan, P.N. Jha, Kavita Shah & Dalip Kumar. (2018) Synthesis and investigations into the anticancer and antibacterial activity studies of β-carboline chalcones and their bromide salts. Bioorganic & Medicinal Chemistry Letters 28:8, pages 1278-1282.
Crossref
Marie Viala, Marie Vinches, Marie Alexandre, Caroline Mollevi, Anna Durigova, Nadia Hayaoui, Krisztian Homicsko, Alice Cuenant, Céline Gongora, Luca Gianni & Diego Tosi. (2018) Strategies for clinical development of monoclonal antibodies beyond first-in-human trials: tested doses and rationale for dose selection. British Journal of Cancer 118:5, pages 679-697.
Crossref
E. A. Zvonova, A. A. Tyurin, A. A. Soloviev & I. V. Goldenkova-Pavlova. (2018) Strategies for Modulation of Pharmacokinetics of Recombinant Therapeutic Proteins. Biology Bulletin Reviews 8:2, pages 124-141.
Crossref
Alexandra C. Braun, Marcus Gutmann, Tessa Lühmann & Lorenz Meinel. (2018) Bioorthogonal strategies for site-directed decoration of biomaterials with therapeutic proteins. Journal of Controlled Release 273, pages 68-85.
Crossref
Andrew Lucas, Lauren Price, Allison Schorzman, Mallory Storrie, Joseph Piscitelli, Juan Razo & William Zamboni. (2018) Factors Affecting the Pharmacology of Antibody–Drug Conjugates. Antibodies 7:1, pages 10.
Crossref
Kinam Park. (2018) Size- and site-dependent distribution of therapeutic proteins into thoracic lymph. Journal of Controlled Release 272, pages 182.
Crossref
Cong Wei, Dian Su, Jian Wang, Wenying Jian & Donglu Zhang. (2018) LC–MS Challenges in Characterizing and Quantifying Monoclonal Antibodies (mAb) and Antibody-Drug Conjugates (ADC) in Biological Samples. Current Pharmacology Reports 4:1, pages 45-63.
Crossref
Molly Graveno & Robert E. StratfordJr.Jr.. 2018. ADME Processes in Pharmaceutical Sciences. ADME Processes in Pharmaceutical Sciences 241 270 .
Mei Han, Josh T. Pearson, Yunan Wang, Dwight Winters, Marcus Soto, Dan A. Rock & Brooke M. Rock. (2017) Immunoaffinity capture coupled with capillary electrophoresis - mass spectrometry to study therapeutic protein stability in vivo. Analytical Biochemistry 539, pages 118-126.
Crossref
Hsiangkuo Yuan, Clinton G. Lauritsen, Eric A. Kaiser & Stephen D. Silberstein. (2017) CGRP Monoclonal Antibodies for Migraine: Rationale and Progress. BioDrugs 31:6, pages 487-501.
Crossref
Thais B. Fernandes, Micael R. Cunha, Renata P. Sakata, Thalita M. Candido, André R. Baby, Maurício T. Tavares, Euzébio G. Barbosa, Wanda P. Almeida & Roberto Parise-Filho. (2017) Synthesis, Molecular Modeling, and Evaluation of Novel Sulfonylhydrazones as Acetylcholinesterase Inhibitors for Alzheimer's Disease. Archiv der Pharmazie 350:11, pages 1700163.
Crossref
Zheng Lu, Jennifer Sheng & Wenhui Zhang. 2017. Protein Therapeutics. Protein Therapeutics 311 340 .
Imlimaong Aier, Pritish Kumar Varadwaj & Utkarsh Raj. (2016) Structural insights into conformational stability of both wild-type and mutant EZH2 receptor. Scientific Reports 6:1.
Crossref
Weirong Wang & Honghui Zhou. (2016) Pharmacological considerations for predicting PK/PD at the site of action for therapeutic proteins. Drug Discovery Today: Technologies 21-22, pages 35-39.
Crossref
Jian Wang, Huidong Gu, Ang Liu, Alexander Kozhich, Vangipuram Rangan, Heather Myler, Linlin Luo, Richard Wong, Huadong Sun, Bonnie Wang, Heather E Vezina, Shrikant Deshpande, Yan Zhang, Zheng Yang, Timothy V Olah, Anne-Francoise Aubry, Mark E Arnold, Renuka Pillutla & Binodh DeSilva. (2016) Antibody–drug conjugate bioanalysis using LB-LC–MS/MS hybrid assays: strategies, methodology and correlation to ligand-binding assays. Bioanalysis 8:13, pages 1383-1401.
Crossref